ARK ETF TR - GENOMIC REV ETF (ARKG)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / GENOMIC REV ETF
Total 13F shares
23,358,292
Share change
-2,235,031
Total reported value
$1,745,083,472
Put/Call ratio
185%
Price per share
$74.72
Number of holders
458
Value change
-$179,706,452
Number of buys
207
Number of sells
217

Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q3 2021

As of 30 Sep 2021 ARK ETF TR - GENOMIC REV ETF (ARKG) had 458 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 23,358,292 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, BANK OF AMERICA CORP /DE/, LPL Financial LLC, UBS Group AG, WELLS FARGO & COMPANY/MN, Eversept Partners, LP, COMMONWEALTH EQUITY SERVICES, LLC, ADVISOR GROUP HOLDINGS, INC., CITIGROUP INC, and ROYAL BANK OF CANADA.
This table shows 461 institutional shareholders of the security as of 30 Sep 2021.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.